Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

High-proportion spliced-in titin truncating variants in African and European ancestry in the All of Us Research Program

Abstract

High-proportion spliced-in titin truncating variants (hiPSI TTNtvs) have been associated with an increased risk of atrial fibrillation, dilated cardiomyopathy (DCM) and heart failure in individuals of European ancestry1. However, similar data in individuals of African ancestry are lacking. Here we examined the association of hiPSI TTNtvs with atrial fibrillation, DCM and heart failure in individuals of African ancestry using data from the All of Us Research Program. Among 38,154 individuals of African ancestry, 169 (0.4%) individuals carried a hiPSI TTNtv. hiPSI TTNtv carriers were at a higher risk of developing atrial fibrillation (adjusted hazard ratio (HRadj) 2.42, 95% confidence interval (CI) 1.52–3.85), DCM (HRadj 2.82, 95% CI 1.81–4.39) and heart failure (HRadj 2.07, 95% CI 1.43–3.00) compared with noncarriers. The association of hiPSI TTNtvs with atrial fibrillation, DCM and heart failure was similar in individuals of African ancestry and those of European ancestry. Therefore, genetic testing for hiPSI TTNtvs may permit early identification of carriers and support preventive measures to reduce the likelihood of heart failure development both in individuals of European ancestry and in individuals of African ancestry.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Cumulative incidence of study outcomes stratified by hiPSI TTNtv carrier status in individuals of African ancestry.
Fig. 2: Cumulative incidence of study outcomes stratified by hiPSI TTNtv carrier status in individuals of European ancestry.

Similar content being viewed by others

Data availability

This study used the All of Us Research Program Controlled Tier Dataset version 7 (C2022Q4R9 Curated Data Repository), which is available in the All of Us Researcher Workbench. Data used for the current study are available to approved users of the All of Us Researcher Workbench (https://workbench.researchallofus.org/login). Controlled tier access provides access to genetic data on the All of Us Researcher Workbench and requires the completion of additional training.

Code availability

Code utilized in this study will be made available to All of Us Researcher Workbench users on contacting the study team.

References

  1. Haggerty, C. M. et al. Genomics-first evaluation of heart disease associated with titin-truncating variants. Circulation 140, 42–54 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Santiago, C. F., Huttner, I. G. & Fatkin, D. Titin-related cardiomyopathy: is it a distinct disease? Curr. Cardiol. Rep. 24, 1069–1075 (2022).

    Article  PubMed  Google Scholar 

  3. Schafer, S. et al. Titin-truncating variants affect heart function in disease cohorts and the general population. Nat. Genet. 49, 46–53 (2017).

    Article  CAS  PubMed  Google Scholar 

  4. Herman, D. S. et al. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 366, 619–628 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Akinrinade, O., Alastalo, T. P. & Koskenvuo, J. W. Relevance of truncating titin mutations in dilated cardiomyopathy. Clin. Genet. 90, 49–54 (2016).

    Article  CAS  PubMed  Google Scholar 

  6. Akinrinade, O., Koskenvuo, J. W. & Alastalo, T. P. Prevalence of titin truncating variants in general population. PLoS ONE 10, e0145284 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Roberts, A. M. et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci. Transl. Med. 7, 270ra276 (2015).

    Article  Google Scholar 

  8. Huggins, G. S. et al. Prevalence and cumulative risk of familial idiopathic dilated cardiomyopathy. JAMA 327, 454–463, (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Tsao, C. W. et al. Heart Disease and Stroke Statistics-2023 Update: a report from the American Heart Association. Circulation 147, e93–e621 (2023).

    Article  PubMed  Google Scholar 

  10. All of Us Research Program Investigators et al. The “All of Us” Research Program. N. Engl. J. Med. 381, 668–676 (2019).

  11. Genomic research data quality report. All of Us Research Program https://support.researchallofus.org/hc/en-us/articles/4617899955092-All-of-Us-Genomic-Quality-Report (2023).

Download references

Acknowledgements

The AoURP is supported by the National Institutes of Health, Office of the Director: Regional Medical Centers: 1 OT2 OD026549; 1 OT2 OD026554; 1 OT2 OD026557; 1 OT2 OD026556; 1 OT2 OD026550; 1 OT2 OD 026552; 1 OT2 OD026553; 1 OT2 OD026548; 1 OT2 OD026551; 1 OT2 OD026555; IAA #: AOD 16037; Federally Qualified Health Centers: HHSN 263201600085U; Data and Research Center: 5 U2C OD023196; Biobank: 1 U24 OD023121; The Participant Center: U24 OD023176; Participant Technology Systems Center: 1 U24 OD023163; Communications and Engagement: 3 OT2 OD023205; 3 OT2 OD023206; and Community Partners: 1 OT2 OD025277; 3 OT2 OD025315; 1 OT2 OD025337; 1 OT2 OD025276. In addition, the AoURP would not be possible without the partnership of its participants. P.A. is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) awards (R01HL160982, R01HL163852, R01HL163081 and K23HL146887).

Author information

Authors and Affiliations

Authors

Contributions

P.A. conceptualized and designed the study. P.A., N.S.S., A.P., N.P., P.L. and G.A. acquired, analyzed or interpreted data. P.A., N.S.S., A.P., N.P., P.L. and G.A. drafted the paper. All authors performed critical revisions of the paper. A.P. did the statistical analysis. P.A. and P.L. were responsible for supervision.

Corresponding author

Correspondence to Pankaj Arora.

Ethics declarations

Competing interests

P.A. reports grant support from Merck Sharp & Dohme LLC and Bristol-Myers Squibb and consulting income from Bristol-Myers Squibb, which are all unrelated to this work. The other authors declare no competing interests.

Peer review

Peer review information

Nature Cardiovascular Research thanks the anonymous reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shetty, N.S., Pampana, A., Patel, N. et al. High-proportion spliced-in titin truncating variants in African and European ancestry in the All of Us Research Program. Nat Cardiovasc Res 3, 140–144 (2024). https://doi.org/10.1038/s44161-023-00417-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-023-00417-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing